Experts at UT MD Anderson have numerous presentations throughout the ESMO Congress 2026 program. Note: Times are listed in either CEST (Central European Summer Time) or CET (Central European Time) as noted for each day.
Experts at UT MD Anderson have numerous presentations throughout the ESMO Congress 2026 program. Note: Times are listed in either CEST (Central European Summer Time) or CET (Central European Time) as noted for each day.
Friday, October 23 (All times are listed in CEST)
Transforming oncology with generative AI and autonomous tools
Educational session
13:30–15:00 (1:30–3 p.m.) │Cordoba Auditorium — Hall 4
Validating AI for oncology: Navigating the road to clinical implementation
14:30–14:45 (2:30–2:45 p.m.)
Presenter: Caroline Chung, M.D.
YO Mentorship session
Young oncologist session
13:30–14:30 (1:30–2:30 p.m.) │Toledo Auditorium — NCC
Early-phase clinical trials
Presenter: Timothy Yap, M.B.B.S., Ph.D.
Emerging therapeutic strategies in advanced prostate cancer
Special symposium
16:15–17:45 (4:15–5:45 p.m.) │Burgos Auditorium — Hall 3
Chair: Ana Aparicio, M.D.
New targets (ADCs, new biologies)
17:15–17:35 (5:15–5:35 p.m.)
Presenter: Ana Aparicio, M.D.
Saturday, October 24 (All times are listed in CEST)
Cellular therapy in solid tumors
Educational session
08:30–10:00 (8:30–10 a.m.) │Madrid Auditorium — Hall 4
Logistics of cellular therapy
09:10–09:30 (9:10–9:30 a.m.)
Presenter: Ecaterina Dumbrava, M.D.
Updates on myeloid neoplasms with a focus on medical oncology practice
Educational session
16:30–18:00 (4:30–6 p.m.) │Malaga Auditorium — Hall 3
Current treatment landscape of AML based on a comprehensive genomic assessment
16:30–16:50 (4:30–4:50 p.m.)
Presenter: Courtney DiNardo, M.D.
Sunday, October 25 (All times are listed in CET)
More cures in early melanoma
Multidisciplinary session
14:45–16:00 (2:45–4 p.m.) │Leon Auditorium — Hall 4
Pathological response for the win
15:30–15:50 (3:30–3:50 p.m.)
Presenter: Victor Prieto, M.D., Ph.D.
Monday, October 26 (All times are listed in CET)
New targets and strategies
Special symposium
08:30–10:00 (8:30–10 a.m.) │Leon Auditorium — Hall 4
Chair: Timothy Yap, M.B.B.S., Ph.D.
New small molecules
09:15–09:30 (9:15–9:30 a.m.)
Presenter: Timothy Yap, M.B.B.S., Ph.D.
From science to clinical use: Emerging systemic therapies for lung cancer
Educational session
10:15–11:45 (10:15–11:45 a.m.) │Almeria Auditorium — Hall 9
Biology and mechanisms of action of novel immunotherapies
10:35–10:55 (10:35–10:55 a.m.)
Presenter: Tina Cascone, M.D., Ph.D.
Emerging biological agents and their role in innate immunity modulation
Special symposium
14:45–16:15 (2:45–4:15 p.m.) │Leon Auditorium — Hall 4
Chair: Stéphane Champiat, M.D., Ph.D.
Bispecific antibodies
14:45–15:00 (2:45–3 p.m.)
Presenter: Stéphane Champiat, M.D., Ph.D.
IO-based systemic therapy in head and neck cancers
Special symposium
16:30–18:00 (4:30–6 p.m.) │Granada Auditorium — Hall 4
IO-based systemic therapy (including patient selection)
16:30–16:45 (4:30–4:45 p.m.)
Presenter: Renata Ferrarotto, M.D.
Give Now
Your gift will help make a tremendous difference.
Research Areas
Find out about the four types of research taking place at UT MD Anderson.
Subscribe
Get the latest information on our cancer breakthroughs.